Dec. 15 at 5:18 PM
$SANA ready for a breakout
$SANA is pushing the boundaries of what's possible in biotech!
Hypoimmune islet cells surviving & producing insulin in T1D patients WITHOUT immunosuppression (NEJM data)
Stem cell-derived SC451: off-the-shelf potential cure, IND filing as early as 2026
In vivo CAR-T platform advancing for cancer & autoimmune
Fresh Nature Biotech pub on precise HSC gene editing
Just broke
$5 on breakout momentum – this could be the closest we've ever been to curing Type 1 Diabetes. Cash runway into late 2026. Loading up for the long haul! 💉🔥
#Biotech #SANA #DiabetesCure